Akin to the in vitro results, when NSD2 was depleted in myeloma cells (Fig. S5h), the reassembly of GFP-SRC-3 FL was significantly inhibited, whereas it was enhanced when NSD2 was overexpressed in vivo (Fig. 5j). Here, NSD2 is linked to plasma cell myeloma.